Model of robust induction of glomerulosclerosis in mice: Importance of genetic background

Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

Barry M. Brenner, Mark E. Cooper, Dick de Zeeuw et al. · New England Journal of Medicine · 2001 · 7.5K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes

Edmund J. Lewis, Lawrence G. Hunsicker, William R. Clarke et al. · New England Journal of Medicine · 2001 · 6K citations · Full text

Medicine, Nephrology, Pharmacology +16

The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes

Hendrik Lehnert, Jens Brøchner‐Mortensen, Ramón Gomis et al. · New England Journal of Medicine · 2001 · 2.9K citations

Medicine, Pharmacology, Pharmacotherapy +17

[Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes].

Hans‐Henrik Parving, Hendrik Lehnert, Jens Brøchner‐Mortensen et al. · PubMed · 2001 · 2.5K citations

Medicine, Pharmacology, Pharmacotherapy +17

Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass.

Sharon Anderson, Timothy W. Meyer, Helmut G. Rennke et al. · Journal of Clinical Investigation · 1985 · 942 citations · Full text

Medicine, Nephrology, Pharmacotherapy +17